Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « reaction »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
reactants < reaction < reactions  Facettes :

List of bibliographic references indexed by reaction

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000036 (2020) B P Hibler [États-Unis] ; A. Markova [États-Unis]Treatment of severe cutaneous adverse reaction with tocilizumab.
000536 (2020) Batool Mutar MahdiCOVID-19 type III hypersensitivity reaction
000A41 (2019) Rosaria Del Giorno [Suisse] ; Alfonso Iodice [Suisse] ; Cristina Mangas [Suisse] ; Luca Gabutti [Suisse]New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review.
001002 (2019) Sultan M. AlmogairenAbatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice
001115 (2018) Rose I. Massolino [Australie] ; Pravin Hissaria [Australie] ; Anita Lee [Australie] ; Susanna M. Proudman [Australie]Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis.
001205 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
001403 (2018) Gabriele Cortellini [Italie] ; Fabio Mascella [Italie] ; Margherita Simoncelli [Italie] ; Domenico Lippolis [Italie] ; Maria Cristina Focherini [Italie] ; Fabio Cortellini [Italie] ; Chiara Cherubini [Italie] ; Barbara Gavioli [Italie] ; Giorgio Ballardini [Italie]Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction.
001458 (2018) Hisato Iriki [Japon] ; Takeshi Ouchi [Japon] ; Hiromi Ito [Japon] ; Miho Sawada [Japon] ; Miho Mukai [Japon] ; Hisashi Nomura [Japon] ; Yuko Baba [Japon] ; Takeya Adachi [Japon] ; Takeru Funakoshi [Japon] ; Masayuki Amagai [Japon] ; Hayato Takahashi [Japon]Case of lamotrigine-induced drug adverse reaction under tocilizumab treatment with clinical and virological features of drug-induced hypersensitivity syndrome.
001536 (2017) Elina Zuelgaray ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France]Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease: A Case Report
001593 (2017) Elina Zuelgaray [France] ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France]Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.
001780 (2017) Yoann Ladner [France] ; Silvia Mas [France] ; Gaelle Coussot [France] ; Killian Bartley [France] ; Jérôme Montels [France] ; Jacques Morel [France] ; Catherine Perrin [France]Integrated microreactor for enzymatic reaction automation: An easy step toward the quality control of monoclonal antibodies.
001956 (2016) C. Boin [France] ; S. Lambert [France] ; P. Thomann [France] ; O. Aujoulat [France] ; P. Kieffer [France][Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
001978 (2016) Gianfranco Vitiello [Italie] ; Boaz Palterer [Italie] ; Paola Parronchi [Italie] ; Daniele Cammelli [Italie]Tocilizumab-induced mucosal ulcers in a patient with relapsing polychondritis: An adverse drug reaction?
001B50 (2016) Lucille Desallais [France] ; Caroline Bouchez [France] ; Hadley Mouhsine [France] ; Gabriel Moreau [France] ; Rojo Ratsimandresy [France] ; Matthieu Montes [France] ; Hervé Do [France] ; Françoise Quintin-Colonna [France] ; Jean-François Zagury [France]Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys
002408 (2014) Konstantinos Savvatis [Oman] ; Irene Müller ; Matthias Fröhlich ; Kathleen Pappritz ; Christin Zietsch ; Nazha Hamdani ; Karsten Grote ; Bernhard Schieffer ; Karin Klingel ; Sophie Van Linthout ; Wolfgang A. Linke ; Heinz-Peter Schultheiss ; Carsten TschöpeInterleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis.
003071 (2013) Y. Tanaka ; T. Takeuchi [Japon] ; K. Amano ; E. Sato [Japon] ; M. Nawata ; H. Nagasawa ; D. Hoshi [Japon] ; K. Saito ; S. Fukuyo ; K. Hanami ; H. Kameda [Japon] ; T. Kurasawa ; Y. Kaneko [Japon] ; H. Yamanaka [Japon]AB0586 104-weeks assessments of clinical and structural remission in rheumatoid arthritis patients with tocilizumab from the reaction study
003276 (2013) A. M. Arredondo ; A. Escobar-Trujillo ; J. Londono [Colombie] ; F. Gonzalez-Malaver ; J. Bello-Gualtero ; C. Guzman-Vergara ; A. Mesa-Betancourt ; R. Valle-O AteAB0203 Prevalence of tuberculin skin test reaction positivity in a colombian cohort of rheumatoid arthritis patients on biologic therapy
003943 (2011) Hisashi Yamanaka [Japon] ; Yoshiya Tanaka ; Eisuke Inoue ; Daisuke Hoshi ; Shigeki Momohara ; Kentaro Hanami ; Naoki Yunoue ; Kazuyoshi Saito ; Kouichi Amano ; Hideto Kameda ; Tsutomu TakeuchiEfficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
003954 (2011) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka ; Koichi Amano ; Daisuke Hoshi ; Masao Nawata ; Hayato Nagasawa ; Eri Sato ; Kazuyoshi Saito ; Yuko Kaneko ; Shunsuke Fukuyo ; Takahiko Kurasawa ; Kentaro Hanami ; Hideto Kameda ; Hisashi YamanakaClinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
003B95 (2011) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Koichi Amano [Japon] ; Daisuke Hoshi [Japon] ; Masao Nawata [Japon] ; Hayato Nagasawa [Japon] ; Eri Sato [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Shunsuke Fukuyo [Japon] ; Takahiko Kurasawa [Japon] ; Kentaro Hanami [Japon] ; Hideto Kameda [Japon] ; Hisashi Yamanaka [Japon]Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients-REACTION 52-week study
004273 (????) Lotta Ljung [Suède] ; Johan Smeds ; Gunilla Persson ; Lena Jirlén ; Göran Toolanen[Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "reaction" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "reaction" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    reaction
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021